Corona Virus Net is the web resource for anyone interested in Coronaviruses. Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (COVID-19) is a new strain that has not been previously identified in humans. Coronaviruses are zoonotic, meaning they are transmitted between animals and humans. Common signs of infection include respiratory symptoms, fever, cough, and shortness of breath. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing. Also avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing.
A pneumonia of unknown cause detected in Wuhan, China was first reported to the WHO on 31 December 2019. The outbreak of COVID-19 was declared a Public Health Emergency of International Concern on 30 January 2020 by the WHO. As of March 11th, the WHO declared the rapidly spreading coronavirus outbreak a pandemic, acknowledging that the virus will likely spread to all countries in the world.
The objectives of Corona Virus Net are to be the public and professional information resource for coronaviruses and to serve as a network in the exchange of information and news related to coronaviruses. What do you know about the novel Coronavirus that is causing a health emergency?
- Coronavirus daily news updates, June 27: What to know today about COVID-19 in the Seattle area, Washington state and the world - The Seattle Times
Mon, 27 Jun 2022 13:28 GMT
- Illinois Coronavirus Updates: Chicago Returns to ‘High' Alert Level, BA.5 Subvariant - NBC Chicago
Mon, 27 Jun 2022 18:31 GMT
- California coronavirus updates: Pfizer says tweaked vaccine offers better protection against omicron - Capital Public Radio News
Mon, 27 Jun 2022 19:19 GMT
- Epstein-Barr may play a role in some long COVID; coronavirus can impair blood sugar processing by organs - Reuters.com
Mon, 27 Jun 2022 19:23 GMT
- Visiting & Camps - Coronavirus Response - Duke's Coronavirus Response
Mon, 27 Jun 2022 14:30 GMT
- FACTBOX-Worldwide coronavirus cases cross 541.29 million, death toll at 6739927 - WTVB
Mon, 27 Jun 2022 11:42 GMT
- Coronavirus in Colorado: COVID-19 updates for June 27-July 3, 2022 - Denver 7 Colorado News
Mon, 27 Jun 2022 18:30 GMT
- North Dakota coronavirus news, June 27: Pandemic mental health aid boosted - Bismarck Tribune
Mon, 27 Jun 2022 10:45 GMT
- CORONAVIRUS: 18 new cases reported in Lyon County Monday - KVOE
Mon, 27 Jun 2022 15:27 GMT
- Governor Lamont Provides Update on Connecticut's Coronavirus Response Efforts - CT.gov
Thu, 23 Jun 2022 18:58 GMT
- Trump swayed by 'dangerous ideas' about coronavirus, Birx tells House panel - The Washington Post
Sat, 25 Jun 2022 00:55 GMT
- Watch now: Coronavirus shutdown pushes restaurant to make saucy new creations - Kingsport Times News
Mon, 27 Jun 2022 19:41 GMT
- Covid Live Updates: Masks, Mandates and China - The New York Times
Mon, 27 Jun 2022 09:11 GMT
- Covid reinfections: How likely are you to catch coronavirus again as cases rise? - Yahoo News
Mon, 27 Jun 2022 17:30 GMT
- America Is in the 'Figure It Out Yourself' Era of the Pandemic - The Atlantic
Mon, 27 Jun 2022 11:00 GMT
- PRO/AH/EDR> COVID-19 update (323): Pfizer vaccine in children, vaccine diplomacy, WHO
Mon, 20 Sep 2021 21:44:10 -0400
COVID-19 -- Worldwide/Unknown
A lower dose of the Pfizer-BioNTech coronavirus vaccine -- one-3rd the amount given to adults and teens -- is safe and triggered a robust immune response in children as young as 5 years old, the drug companies announced in a news release Monday morning.
The finding, eagerly anticipated by many parents and pediatricians, is a crucial step toward the 2-shot coronavirus vaccine regimen becoming available for younger school-aged children, perhaps close to Halloween.
The companies still must
- Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine Mon, 27 Jun 2022 06:00:00 -0400
Humans commonly have low level antibodies to poly(ethylene) glycol (PEG) due to environmental exposure. Lipid nanoparticle (LNP) mRNA vaccines for SARS-CoV-2 contain small amounts of PEG, but it is not known whether PEG antibodies are enhanced by vaccination and what their impact is on particle-immune cell interactions in human blood. We studied plasma from 130 adults receiving either the BNT162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna) mRNA vaccines or no SARS-CoV-2 vaccine for PEG-specific...
- Pediatric and Adolescent COVID-19 Vaccination Side Effects: A Retrospective Cohort Study of Iranian Teenage group in 2021 Mon, 27 Jun 2022 06:00:00 -0400
CONCLUSION: Our study shows that Sinopharm and Soberana (PastoCoVac) COVID-19 vaccine are generally safe with no serious side effects in fewer than 18 years old. COVID19 infection and reinfection can occur after vaccination, but the incidence is actually tolerable and significantly lower than in the unvaccinated group. This article is protected by copyright. All rights reserved.
- Mutations in the 3'-PPT Lead to HIV-1 Replication without Integration Mon, 27 Jun 2022 06:00:00 -0400
Integration of the reverse-transcribed genome is a critical step of the retroviral life cycle. Strand-transfer inhibitors (INSTIs) used for antiretroviral therapy inhibit integration but can lead to resistance mutations in the integrase gene, the enzyme involved in this reaction. A significant proportion of INSTI treatment failures, particularly those with second-generation INSTIs, show no mutation in the integrase gene. Here, we show that replication of a selected dolutegravir-resistant virus...
- Radiographic and Clinical Analysis of Cranio-Maxillofacial Complications of Cavernous Sinus Thrombosis Among 256 COVID-19 Patients Mon, 27 Jun 2022 06:00:00 -0400
BACKGROUND: A heavy burden of cranio-maxillofacial complications may be encountered in corona virus disease-2019 patients due to the associated coagulopathy and inflammatory consequences of the disease. This study aims to describe clinical and radiographic features of these complications in 256 patients who developed 1 or more of the following complications: cavernous sinus thrombosis, osteomyelitis or necrosis of the jaws.
- In-hospital mortality in SARS-CoV-2 stratified by sex diffrences: A retrospective cross-sectional cohort study Mon, 27 Jun 2022 06:00:00 -0400
CONCLUSIONS: Male gender was an independent predictor of in-hospital mortality in this study. The mortality rate among male SARS-CoV-2 patients was 2.8 times higher when compared with females.
- Delayed Diagnosis and Multi-TKI Intolerance: A Case Report of CML Concurrent With COVID-19 Mon, 27 Jun 2022 06:00:00 -0400
CONCLUSION: The offset effect between CML and SARS-CoV-2 infection was supposed to be the underlying mechanism for the absence of leukocytosis or splenomegaly. The impact of immune network by SARS-CoV-2 preserved and disrupted the patient's response to TKIs despite the virus' ablation. We suggest that a continued elevation of basophils may be a useful indicator for CML concurrent with COVID-19, and individualized treatment with adjusted dosage and suitable type of TKIs should be considered to...
- Vaccine Passport and Traveler Behaviors in the New Market of the Domestic and International Tourism Industry Facing the With-Corona Era Mon, 27 Jun 2022 06:00:00 -0400
To ensure a smooth and rapid recovery of tourism, countries around the world are stepping up vaccinations against COVID-19. China, in particular has a very high vaccination rate due to its own vaccine production. Following this trend, many countries have started introducing vaccine passports as an alternative solution to verify valid and vaccinated travelers. This study attempted to understand the fundamental perceptions of travelers' intentions using vaccine passports. A total of 601 samples...
- Exploring the mutual influence among the social innovation factors amid the COVID-19 pandemic Mon, 27 Jun 2022 06:00:00 -0400
From the triple bottom line, the social aspect has received relatively limited attention during the Corona Virus Disease (COVID-19) pandemic, particularly in the emerging economies. Social innovation factors help improve the sustainability performance of the companies. This study develops a social innovation decision framework and analyses the interrelationships among social innovation factors considering the COVID-19 situation. For this purpose, the Decision-Making Trial and Evaluation...
- SARS-CoV-2 seroprevalence in children, parents and school personnel from June 2020 to April 2021: cohort study of 55 schools in Switzerland Sun, 26 Jun 2022 06:00:00 -0400
CONCLUSIONS: We observed similar seroprevalence in children and parents, somewhat lower in school personnel in March-April 2021 and striking variation between districts and school communities. Children's seroprevalence was higher in classes with infected main teachers and from families with infected parents.
- Experiences and psychosocial predictors of professional function among intensive care nurses under the shadow of Covid-19: A mixed-methods study Sun, 26 Jun 2022 06:00:00 -0400
CONCLUSIONS: The intensity of the experiences and psych-social phenomena, is not affected by exposure to treatment of COVID-19 patients. The relationships between the study variables emphasize the importance of initiated and ongoing interventions to reduce uncertainty, address burnout, and strengthen hope. Improvement in these indices may lead to better ICU nurses' professional functioning and their work life well-being.